Skip to Main Content

Chapter 22. Dyslipidemia MTM Data Set

Which lipid marker remains valid if the patient is not fasting at the time the lipid panel is completed?

a. LDL

b. HDL

c. TG


Answer b.

All of the following are consistent with the definition of ASCVD EXCEPT:

a. congestive heart failure.

b. myocardial infarction.

c. abdominal aortic aneurysm.

d. peripheral arterial disease.

Answer a.

Which statin is most appropriate for a 58-year-old patient diagnosed with type 2 diabetes mellitus and a 10-year ASCVD risk of 15%?

a. Simvastatin 40 mg daily

b. Pravastatin 80 mg daily

c. Atorvastatin 20 mg daily

d. Rosuvastatin 20 mg daily

Answer d.

Which is the best description of rhabdomyolysis in living room language?

a. A serious condition due to degradation of muscle tissue caused by statins; associated with myalgias and myoglobinuria

b. A severe condition where the muscles are breaking down, presenting with muscle weakness and pain, along with cola-colored urine

c. A potential side effect with HMG CoA reductase inhibitors; patient may experience muscle pain (myalgia), weakness, or cramps

d. Something bad that happens, a bad reaction, an unexplained or unwanted effect

Answer b.

A 42-year-old patient with dyslipidemia is new to MTM service. After performing a medication therapy review with the patient, the pharmacist completes a medication action plan (MAP). Which statement best represents the type of information that should be included in the patient’s MAP?

a. Take simvastatin 20 mg tablet nightly for cholesterol.

b. Side effects experienced with this medication may include myalgias, myopathy, and rhabdomyolysis.

c. Remember to take simvastatin every night; use a pillbox or alarm reminder to help remember.

d. Pharmacist will call Dr. Smith to discuss switching simvastatin to a stronger medication for cholesterol.

Answer c.


Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.